Federated Hermes’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170 | Sell |
137
-465,121
| -100% | -$577K | ﹤0.01% | 2048 |
|
|
2025
Q1 | $549K | Buy |
465,258
+16,960
| +4% | +$20K | ﹤0.01% | 1279 |
|
|
2024
Q4 | $820K | Buy |
448,298
+5,374
| +1% | +$9.83K | ﹤0.01% | 1166 |
|
|
2024
Q3 | $753K | Sell |
442,924
-3,930
| -0.9% | -$6.68K | ﹤0.01% | 1219 |
|
|
2024
Q2 | $612K | Buy |
+446,854
| New | +$612K | ﹤0.01% | 1263 |
|
|
2023
Q4 | – | Sell |
-19
| Closed | -$159 | – | 2163 |
|
|
2023
Q3 | $159 | Sell |
19
-33,518
| -100% | -$280K | ﹤0.01% | 2073 |
|
|
2023
Q2 | $446K | Buy |
33,537
+33,536
| +3,353,600% | +$446K | ﹤0.01% | 1410 |
|
|
2023
Q1 | $12 | Hold |
1
| – | – | ﹤0.01% | 2110 |
|
|
2022
Q4 | $8 | Hold |
1
| – | – | ﹤0.01% | 2144 |
|
|
2022
Q3 | $1K | Sell |
1
-4,608
| -100% | -$4.61M | ﹤0.01% | 2069 |
|
|
2022
Q2 | $20K | Buy |
+4,609
| New | +$20K | ﹤0.01% | 1765 |
|
|
2021
Q2 | – | Sell |
-59,024
| Closed | -$1.97M | – | 2296 |
|
|
2021
Q1 | $1.97M | Sell |
59,024
-420,612
| -88% | -$14M | ﹤0.01% | 1114 |
|
|
2020
Q4 | $12.4M | Buy |
479,636
+147,790
| +45% | +$3.83M | 0.03% | 584 |
|
|
2020
Q3 | $3.28M | Buy |
+331,846
| New | +$3.28M | 0.01% | 838 |
|
|
2018
Q4 | – | Sell |
-1,600,000
| Closed | -$8.66M | – | 2269 |
|
|
2018
Q3 | $8.66M | Buy |
+1,600,000
| New | +$8.66M | 0.02% | 622 |
|
|
2016
Q3 | – | Sell |
-576
| Closed | -$4K | – | 2153 |
|
|
2016
Q2 | $4K | Sell |
576
-33
| -5% | -$229 | ﹤0.01% | 1925 |
|
|
2016
Q1 | $5K | Buy |
+609
| New | +$5K | ﹤0.01% | 1876 |
|
|
2015
Q2 | – | Sell |
-838
| Closed | -$5K | – | 2032 |
|
|
2015
Q1 | $5K | Buy |
+838
| New | +$5K | ﹤0.01% | 1868 |
|